Wed, 22nd Oct 2014 11:16
** GlaxoSmithKline rises 4.6 pct after reporting Q3EPS of 27.9p, up 5 pct and above the 24p forecast by analysts.
** Biggest one-day rise for stock since April.
** Top riser on FTSE 100 at 1100 GMT.
** Q3 dividend maintained at 19p/shr FY 2014 div expected tobe 80p, up 3 pct, with 2015 div maintained at same level as2014.
** GSK ADRs up 3.5 pct in New York pre-market trading. (RM: alasdair.pal.thomsonreuters.com@reuters.net)
May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a...
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U....
FTSE 100 down 0.3%, FTSE 250 off 0.2% *
(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal...
Glaxosmithkline (GSK)